Treatment with gepirone extended-release (ER) produces significantly higher response rates than placebo in patients with moderate depression

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1495, 2005-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gabapentin Extended-Release Tablets for the Treatment of Patients with Postherpetic Neuralgia: A Randomized, Double-Blind, Placebo-Controlled, Multicentre Study

By Wallace Mark S.  

Clinical Drug Investigation, Vol. 30, Iss. 11, 2010-11 ,pp. : 765-776

Adis International

Access to resources Recommend Favorite

Extended-release lamotrigine in the treatment of patients with epilepsy

By Syed Tanvir U   Sajatovic Martha  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 9, 2010-06 ,pp. : 1579-1585

Informa Healthcare

Access to resources Recommend Favorite

Single- and Multiple-Dose Pharmacokinetics and Tolerability of Gepirone Extended-Release

By Timmer C.J.  

Clinical Drug Investigation, Vol. 22, Iss. 12, 2002-01 ,pp. : 819-826

Adis International

Access to resources Recommend Favorite

Extended-Release Formulations for the Treatment of Epilepsy

By Bialer Meir  

CNS Drugs, Vol. 21, Iss. 9, 2007-01 ,pp. : 765-774

Adis International

Access to resources Recommend Favorite

Extended-release (ER) fluvastatin either alone or in combination with ezetimibe appears to effectively lower LDL-cholesterol in patients intolerant to statins

By  

Inpharma, Vol. 1, Iss. 1605, 2007-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite